Long-term weight change after initiating second-generation antidepressants

Journal of Clinical Medicine

Volumn 5, Issue 4, 2016, Pages

  Arterburn, David ^a   Sofer, Tamar ^b   Boudreau, Denise M ^a   Bogart, Andy ^a   Westbrook, Emily O ^a   Theis, Mary Kay ^a   Simon, Greg ^a   Haneuse, Sebastien ^c  

^a GROUP HEALTH RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Adverse effects; Antidepressant; Depression; Obesity; Weight gain

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; CITALOPRAM; DULOXETINE; FLUOXETINE; MIRTAZAPINE; PAROXETINE; SERTRALINE; TRAZODONE; VENLAFAXINE;

ADULT; ANXIETY DISORDER; ARTICLE; BIPOLAR DISORDER; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MALE; RETROSPECTIVE STUDY; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SLEEP DISORDER; WEIGHT CHANGE;

EID: 85048811433     PISSN: None     EISSN: 20770383     Source Type: Journal    
DOI: 10.3390/jcm5040048     Document Type: Article

References (39)

1. U. S. Department of Health and Human Services, Public Health Service, Office of the Surgeon General. The Surgeon General's Call to Action to Prevent and Decrease Overweight and Obesity; U. S. Department of Health and Human Services, Public Health Service, Office of the Surgeon General: Rockville, MD, USA, 2001.
2. Arterburn, D. Obesity. Clin. Evid. 2004, 11, 762-776. [PubMed]
3. Arterburn, D. E.; McDonell, M. B.; Hedrick, S. C.; Diehr, P.; Fihn, S. D. Association of body weight with condition-specific quality of life in male veterans. Am. J. Med. 2004, 117, 738-746. [CrossRef] [PubMed]
4. Simon, G. E. Long-term prognosis of depression in primary care. Bull. World Health Organ. 2000, 78, 439-445. [PubMed]
5. Simon, G. E. Social and economic burden of mood disorders. Biol. Psychiatry 2003, 54, 208-215. [CrossRef]
6. Simon, G. E.; Chisholm, D.; Treglia, M.; Bushnell, D. Course of depression, health services costs, and work productivity in an international primary care study. Gen. Hosp. Psychiatry 2002, 24, 328-335. [CrossRef]
7. Simon, G. E.; Von Korff, M.; Lin, E. Clinical and functional outcomes of depression treatment in patients with and without chronic medical illness. Psychol. Med. 2005, 35, 271-279. [CrossRef] [PubMed]
8. Flegal, K. M.; Carroll, M. D.; Kit, B. K.; Ogden, C. L. Prevalence of obesity and trends in the distribution of body mass index among us adults, 1999-2010. JAMA 2012, 307, 491-497. [CrossRef] [PubMed]
9. Shim, R. S.; Baltrus, P.; Ye, J.; Rust, G. Prevalence, treatment, and control of depressive symptoms in the united states: Results from the national health and nutrition examination survey (nhanes), 2005-2008. J. Am. Board Fam. Med. 2011, 24, 33-38. [CrossRef] [PubMed]
10. Linde, J. A.; Jeffery, R. W.; Finch, E. A.; Simon, G. E.; Ludman, E. J.; Operskalski, B. H.; Ichikawa, L.; Rohde, P. Relation of body mass index to depression and weighing frequency in overweight women. Prev. Med. 2007, 45, 75-79. [CrossRef] [PubMed]
11. Simon, G. E.; Von Korff, M.; Saunders, K.; Miglioretti, D. L.; Crane, P. K.; van Belle, G.; Kessler, R. C. Association between obesity and psychiatric disorders in the us adult population. Arch. Gen. Psychiatry 2006, 63, 824-830. [CrossRef] [PubMed]
12. Heo, M.; Pietrobelli, A.; Fontaine, K. R.; Sirey, J. A.; Faith, M. S. Depressive mood and obesity in us adults: Comparison and moderation by sex, age, and race. Int. J. Obes. (Lond.) 2006, 30, 513-519. [CrossRef] [PubMed]
13. Ogden, C. L.; Carroll, M. D.; Curtin, L. R.; McDowell, M. A.; Tabak, C. J.; Flegal, K. M. Prevalence of overweight and obesity in the united states, 1999-2004. JAMA 2006, 295, 1549-1555. [CrossRef] [PubMed]
14. Flegal, K. M.; Carroll, M. D.; Kuczmarski, R. J.; Johnson, C. L. Overweight and obesity in the united states: Prevalence and trends, 1960-1994. Int. J. Obes. Relat. Metab. Disord. 1998, 22, 39-47. [CrossRef] [PubMed]
15. Paulose-Ram, R.; Safran, M. A.; Jonas, B. S.; Gu, Q.; Orwig, D. Trends in psychotropic medication use among U. S. Adults. Pharmacoepidemiol. Drug Saf. 2007, 16, 560-570. [CrossRef] [PubMed]
16. Keith, S. W.; Redden, D. T.; Katzmarzyk, P. T.; Boggiano, M. M.; Hanlon, E. C.; Benca, R. M.; Ruden, D.; Pietrobelli, A.; Barger, J. L.; Fontaine, K. R.; et al. Putative contributors to the secular increase in obesity: Exploring the roads less traveled. Int. J. Obes. (Lond.) 2006, 30, 1585-1594. [CrossRef] [PubMed]
17. Ricca, V.; Mannucci, E.; Di Bernardo, M.; Rizzello, S. M.; Cabras, P. L.; Rotella, C. M. Sertraline enhances the effects of cognitive-behavioral treatment on weight reduction of obese patients. J. Endocrinol. Investig. 1996, 19, 727-733. [CrossRef]
18. Serretti, A.; Mandelli, L. Antidepressants and body weight: A comprehensive review and meta-analysis. J. Clin. Psychiatry 2010, 71, 1259-1272. [CrossRef] [PubMed]
19. Aronne, L. J.; Segal, K. R. Weight gain in the treatment of mood disorders. J. Clin. Psychiatry 2003, 64 (Suppl. 8), 22-29. [PubMed]
20. Berkowitz, R. I.; Fabricatore, A. N. Obesity, psychiatric status, and psychiatric medications. Psychiatr. Clin. North Am. 2005, 28, 39-54. [CrossRef] [PubMed]
21. Deshmukh, R.; Franco, K. Managing weight gain as a side effect of antidepressant therapy. Cleve Clin. J. Med. 2003, 70. [CrossRef]
22. Kachur, S. G.; Hannan, C. L.; Ward, K. E. Antidepressant-induced weight gain. Med. Health R. I. 2005, 88, 359-361. [PubMed]
23. Schwartz, T. L.; Nihalani, N.; Jindal, S.; Virk, S.; Jones, N. Psychiatric medication-induced obesity: A review. Obes. Rev. 2004, 5, 115-121. [CrossRef] [PubMed]
24. Blumenthal, S. R.; Castro, V. M.; Clements, C. C.; Rosenfield, H. R.; Murphy, S. N.; Fava, M.; Weilburg, J. B.; Erb, J. L.; Churchill, S. E.; Kohane, I. S.; et al. An electronic health records study of long-term weight gain following antidepressant use. JAMA Psychiatry 2014, 71, 889-896. [CrossRef] [PubMed]
25. Qaseem, A.; Snow, V.; Denberg, T. D.; Forciea, M. A.; Owens, D. K.; Clinical Efficacy Assessment Subcommittee of the American College of Physicians. Using second-generation antidepressants to treat depressive disorders: A clinical practice guideline from the american college of physicians. Ann. Intern. Med. 2008, 149, 725-733. [CrossRef] [PubMed]
26. Gartlehner, G.; Gaynes, B. N.; Hansen, R. A.; Thieda, P.; DeVeaugh-Geiss, A.; Krebs, E. E.; Moore, C. G.; Morgan, L.; Lohr, K. N. Comparative benefits and harms of second-generation antidepressants: Background paper for the american college of physicians. Ann. Intern. Med. 2008, 149, 734-750. [CrossRef] [PubMed]
27. Cipriani, A.; Furukawa, T. A.; Salanti, G.; Geddes, J. R.; Higgins, J. P.; Churchill, R.; Watanabe, N.; Nakagawa, A.; Omori, I. M.; McGuire, H.; et al. Comparative efficacy and acceptability of 12 new-generation antidepressants: A multiple-treatments meta-analysis. Lancet 2009, 373, 746-758. [CrossRef]
28. Aubin, H. J.; Farley, A.; Lycett, D.; Lahmek, P.; Aveyard, P. Weight gain in smokers after quitting cigarettes: Meta-analysis. BMJ 2012, 345, e4439. [CrossRef] [PubMed]
29. Saunders, K. D. R.; Stergachis, A. Group health cooperative. In Pharmacoepidemiology, 4th ed.; BL, S., Ed.; John Wiley and Sons: West Sussez, UK, 2005; pp. 223-239.
30. Boudreau, D. M.; Daling, J. R.; Malone, K. E.; Gardner, J. S.; Blough, D. K.; Heckbert, S. R. A validation study of patient interview data and pharmacy records for antihypertensive, statin, and antidepressant medication use among older women. Am. J. Epidemiol. 2004, 159, 308-317. [CrossRef] [PubMed]
31. Buist, D. S.; LaCroix, A. Z.; Brenneman, S. K.; Abbott, T., 3rd. A population-based osteoporosis screening program: Who does not participate, and what are the consequences? J. Am. Geriatr. Soc. 2004, 52, 1130-1137. [CrossRef] [PubMed]
32. Arterburn, D. Bariatric surgery. BMJ 2008, 337, a755. [CrossRef] [PubMed]
33. Seaman, S. R.; White, I. R. Review of inverse probability weighting for dealing with missing data. Stat. Methods Med. Res. 2013, 22, 278-295. [CrossRef] [PubMed]
34. Robbins, J. M.; Hernan, M. A.; Brumback, B. Marginal structural models and causal inference in epidemiology. Epidemiology 2000, 11, 550-560. [CrossRef]
35. Cole, S. R.; Hernan, M. A. Constructing inverse probability weights for marginal structural models. Am. J. Epidemiol. 2008, 168, 656-664. [CrossRef] [PubMed]
36. Follmann, D.; Proschan, M.; Leifer, E. Multiple outputation: Inference for complex clustered data by averaging analyses from independent data. Biometrics 2003, 59, 420-429. [CrossRef] [PubMed]
37. Jain, A. K.; Kaplan, R. A.; Gadde, K. M.; Wadden, T. A.; Allison, D. B.; Brewer, E. R.; Leadbetter, R. A.; Richard, N.; Haight, B.; Jamerson, B. D.; et al. Bupropion SR vs. placebo for weight loss in obese patients with depressive symptoms. Obes. Res. 2002, 10, 1049-1056. [CrossRef] [PubMed]
38. Stahl, S. M.; Pradko, J. F.; Haight, B. R.; Modell, J. G.; Rockett, C. B.; Learned-Coughlin, S. A review of the neuropharmacology of bupropion, a dual norepinephrine and dopamine reuptake inhibitor. Prim. Care Companion J. Clin. Psychiatry 2004, 6, 159-166. [CrossRef] [PubMed]
39. Boudreau, D. M.; Arterburn, D.; Bogart, A.; Haneuse, S.; Theis, M. K.; Westbrook, E.; Simon, G. Influence of body mass index on the choice of therapy for depression and follow-up care. Obesity (Silver Spring) 2013, 21, E303-E313. [CrossRef] [PubMed]